TOI — Oncology Institute Share News
0.000.00%
Last trade - 00:00- $525.91m
- $574.24m
- $502.73m
Brief: The Oncology Institute Set To Join The Russell 2000 And Russell 3000 Indexes
Brief: Oncology Institute- On May 11, 2022, Board Of Co Approved Share Repurchase Program With Authorization To Purchase Up To $20 Million Of Co’S Common Stock
Brief: The Oncology Institute Reports First Quarter 2022 Financial Results And Confirms Full Year 2022 Guidance
Brief: The Oncology Institute Names Mihir Shah As Chief Financial Officer
Brief: Oncology Institute Expands Riverside Location
Brief: The Oncology Institute Reports Q4 And Full Year 2021 Financial Results
Brief: The Oncology Institute Enters Into Value-Based Agreement With Maxheath
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:53 AM
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM
U.S. STOCKS ON THE MOVE-Ocugen, Biogen, Immunovant
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
NASDAQ RESUMED AT 10:01 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM